However, tirzepatide has the significant advantage of FDA approval, which opens the door to insurance coverage
You may request access to, correction of, or deletion of your personal information at any time in accordance with applicable privacy laws, including the California Consumer Privacy Act (CCPA/CPRA) where applicable
Amanda Olsen, PA-C, delivers skin rejuvenation and GLP-ReplaceAddressLinkions at our practice
Retatrutide is a once-weekly injection that mimics three hormones involved in appetite, blood sugar, and how the body uses energy: GLP-1: lowers appetite and blood sugar GIP: lowers appetite and blood sugar Glucagon: increases energy expenditure and the breakdown of stored fat, including fat in the liver The glucagon component is what separates retatrutide from semaglutide, which mimics one hormone (GLP-1), and tirzepatide, which mimics two (GLP-1 and GIP)
Still, clinical decisions depend on approval status, product labeling, side effects, diabetes treatment goals, cardiovascular risk, comorbid conditions, and patient preferences
Follow concise handling protocols to extend shelf life
